Jacquelyn W Chou, MPP, MPL

Pharma Insights

De-risking Market Launch: Leveraging HEOR Evidence Planning to Support Informed Payer Decisions

12/05/2022

Alexandria Portelli, MPH

Andrew Cournoyer, RPh, MBA

The authors discuss how a strategic HEOR evidence-generation plan that comprehensively communicates the value of a new drug helps to ensure that patients have access to innovative drugs and health care stakeholders have access to data to...

The authors discuss how a...

12/05/2022

Journal of Clinical Pathways

Pharma Insights

Navigating Pricing Models for COVID-19 Innovations

08/19/2020

Jacquelyn W Chou, MPP, MPL

Pricing models are important for decision-making because they help to translate preliminary clinical benefit information into longer-term health benefit and economic value. However, in the face of an on-going global...

...

08/19/2020

Journal of Clinical Pathways